| 标题 |
407eP Von Willebrand factor and ADAMTS13 as potential biomarkers for predicting severe adverse events in combination therapy with atezolizumab and bevacizumab for advanced hepatocellular carcinoma |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:H. Takaya; T. Namisaki; N. Nishimura; H. Yoshiji 出版日期:2025 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)